Clinical Trials Browser

Phase 1/2 × Has results × Metastatic Solid Tumors × Clear all

NCT03573544 2024-02-22

This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors.

Phase 1/2 Terminated

54 enrolled 16 charts

Other solid neoplasm

Metastatic Solid Tumors